We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

71 hedge funds and large institutions have $74.5M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,412% more call options, than puts

Call options by funds: $257K | Put options by funds: $17K

37% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 19

5% less funds holding

Funds holding: 75 → 71 (-4)

13% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 15

29% less capital invested

Capital invested by funds: $105M → $74.5M (-$30.1M)

Holders
71
Holders Change
-4
Holders Change %
-5.33%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
26
Reduced
19
Closed
15
Calls
$257K
Puts
$17K
Net Calls
+$240K
Net Calls Change
+$158K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.74M
2
FMBTD
First Midwest Bank Trust Division
Illinois
+$783K
3
Renaissance Technologies
Renaissance Technologies
New York
+$444K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$406K
5
State Street
State Street
Massachusetts
+$402K

Top Sellers

Rank Fund Capital Flow
1
AS
Altshuler Shaham
Israel
-$1.27M
2
Morgan Stanley
Morgan Stanley
New York
-$253K
3
WG
Winton Group
United Kingdom
-$253K
4
JP Morgan Chase
JP Morgan Chase
New York
-$196K
5
UBS Group
UBS Group
Switzerland
-$176K

VBIV Hedge Fund Activity: Q1 2020 in Review

71 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2020, worth a combined $74.5M — down 29% from $105M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of VBIV and 13 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $1.74M. The largest seller was Altshuler Shaham, exiting entirely with an estimated $1.27M sold.

  • 71 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2020, down from 75 in Q4 2019.
  • Funds reported $74.5M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2020, down 29% quarter-over-quarter.
  • 13 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2020 and 15 closed out, a net change of -2 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2020 was BlackRock, an estimated $1.74M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2020 was Altshuler Shaham, an estimated $1.27M sold.

Based on aggregated 13F filings for Q1 2020.